Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy GW Pharmaceuticals stock

Learn how to easily invest in GW Pharmaceuticals stock.

GW Pharmaceuticals plc is a drug manufacturers-general business based in the US. GW Pharmaceuticals shares (GWPH) are listed on the NASDAQ and all prices are listed in US Dollars. GW Pharmaceuticals employs 1,161 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in GW Pharmaceuticals

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – GWPH – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

GW Pharmaceuticals stock price (NASDAQ: GWPH)

Use our graph to track the performance of GWPH stocks over time.

GW Pharmaceuticals shares at a glance

Information last updated 2021-07-04.
52-week range$87.07 - $219.57
50-day moving average $218.22
200-day moving average $167.56
Wall St. target price$201.13
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $1.07

Buy GW Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Robinhood
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
0%
N/A
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
N/A
$20 per year
N/A
Financial advice powered by relationships, not commissions.
TradeStation
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$50
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Sofi Invest
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Moomoo
Stocks
$0
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy GW Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is GW Pharmaceuticals under- or over-valued?

Valuing GW Pharmaceuticals stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of GW Pharmaceuticals's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

GW Pharmaceuticals's PEG ratio

GW Pharmaceuticals's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.37. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into GW Pharmaceuticals's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

GW Pharmaceuticals financials

Revenue TTM $559 million
Gross profit TTM $489.7 million
Return on assets TTM -4.58%
Return on equity TTM -9.62%
Profit margin -12.49%
Book value $23.35
Market capitalisation $6.8 billion

TTM: trailing 12 months

Shorting GW Pharmaceuticals shares

There are currently 693,731 GW Pharmaceuticals shares held short by investors – that's known as GW Pharmaceuticals's "short interest". This figure is 5.2% up from 659,630 last month.

There are a few different ways that this level of interest in shorting GW Pharmaceuticals shares can be evaluated.

GW Pharmaceuticals's "short interest ratio" (SIR)

GW Pharmaceuticals's "short interest ratio" (SIR) is the quantity of GW Pharmaceuticals shares currently shorted divided by the average quantity of GW Pharmaceuticals shares traded daily (recently around 603244.34782609). GW Pharmaceuticals's SIR currently stands at 1.15. In other words for every 100,000 GW Pharmaceuticals shares traded daily on the market, roughly 1150 shares are currently held short.

However GW Pharmaceuticals's short interest can also be evaluated against the total number of GW Pharmaceuticals shares, or, against the total number of tradable GW Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case GW Pharmaceuticals's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 GW Pharmaceuticals shares in existence, roughly 20 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable GW Pharmaceuticals shares, roughly 0 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against GW Pharmaceuticals.

Find out more about how you can short GW Pharmaceuticals stock.

GW Pharmaceuticals share dividends

We're not expecting GW Pharmaceuticals to pay a dividend over the next 12 months.

GW Pharmaceuticals share price volatility

Over the last 12 months, GW Pharmaceuticals's shares have ranged in value from as little as $87.0655 up to $219.5696. A popular way to gauge a stock's volatility is its "beta".

GWPH.US volatility(beta: 1.65)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while GW Pharmaceuticals's is 1.6492. This would suggest that GW Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

GW Pharmaceuticals overview

GW Pharmaceuticals plc, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics from its proprietary cannabinoid product platform in various disease areas. Its lead product is Epidiolex, an oral medicine for the treatment of seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, or tuberous sclerosis complex. The company also develops and markets Sativex for the treatment of spasticity due to multiple sclerosis. In addition, it develops various product candidates for the treatment of schizophrenia, autism spectrum disorder, neuropsychiatric symptom, and neonatal hypoxic ischemic encephalopathy. It primarily operates in Europe, the United Kingdom, the United States, and internationally. GW Pharmaceuticals plc was founded in 1998 and is based in Cambridge, the United Kingdom. .

Frequently asked questions

What percentage of GW Pharmaceuticals is owned by insiders or institutions?
Currently 0.196% of GW Pharmaceuticals shares are held by insiders and 80.351% by institutions.
How many people work for GW Pharmaceuticals?
Latest data suggests 1,161 work at GW Pharmaceuticals.
When does the fiscal year end for GW Pharmaceuticals?
GW Pharmaceuticals's fiscal year ends in December.
Where is GW Pharmaceuticals based?
GW Pharmaceuticals's address is: Sovereign House, Cambridge, United Kingdom, CB24 9BZ
What is GW Pharmaceuticals's ISIN number?
GW Pharmaceuticals's international securities identification number is: US36197T1034
What is GW Pharmaceuticals's CUSIP number?
GW Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 36197T103

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site